Press Releases

Signature Mapping Medical Sciences Receives Order for TBDx Automated Tuberculosis Diagnostic Systems
October 17, 2011
Signature Mapping Medical Sciences Inc. announced today that it has received its first order for three TBDx™ automated tuberculosis (TB) diagnostic systems from the Aurum Institute for Health Research in South Africa.

Signature Mapping TBDx Tuberculosis Diagnostics Solution to Be Deployed in Remote Intensive Case Finding Project
September 14, 2011
Signature Mapping Medical Sciences Inc. announces today through its on-going partnership with the Aurum Institute for Health Research in South Africa, Signature Mapping Medical Sciences, Inc. will be deploying the TBDx automated slide management visualization screening solution as a component of an innovative mobile tuberculosis (TB) case finding project

Applied Visual Sciences Update of Ongoing Business Activities
June 1, 2011
Applied Visual Sciences provides an update of ongoing business activities as of June 1, 2011 in a letter to Shareholders.

Applied Visual Sciences Launches TBDxV™ TB Diagnostic Aid in India
April 25, 2011
Signature Mapping Medical Sciences Inc. has begun TBDxV™ product sales and marketing initiatives through its subsidiary and agents in India. TBDxV, a fully automated tuberculosis (TB) visualization technology to aid in the diagnosis of TB, addresses the approximately 52 million diagnostic slides analyzed by clinical lab technicians each year.

Update on Signature Mapping TBDx Tuberculosis Test Clinical Trial
March 24, 2011
Signature Mapping Medical Sciences Inc.'s TBDx Tuberculosis (TB) diagnostic system is in the final stages of an independently controlled clinical trial, which is nested as a sub-study to the large international Thibela TB study trial being conducted by the Aurum Institute. Aurum provided a detailed progress update to Signature Mapping and its parent company Applied Visual Sciences, Inc. (OTCBB: APVS).

Highly Successful Clinical Trial Results Advance Signature Mapping TBDx Solution to Operational Evaluation in South Africa.
December 22, 2010
Signature Mapping Medical Sciences, the wholly owned medical diagnostic imaging subsidiary of Applied Visual Sciences, announces highly successful intermediary clinical trial results. Signature Mapping TBDx (TBDx) demonstrated an extremely high sensitivity, the ability to locate and identify more TB bacilli, a major shortcoming in worldwide TB diagnostics.

Applied Visual Sciences Receives Patent for Advanced Imaging Technology/Automated Target Recognition.
October 25, 2010
Applied Visual Sciences announces the issuance of United States patent 7,817,833, titled "System and Method for Identifying a Feature of Interest in Hyperspectral Data," by the United States Patent and Trademark Office (USPTO). The patent extends APVS's existing patent protection into the image analysis domain where multiple images or pictures are created and utilized for automated computer analysis and assessment.

Applied Visual Sciences Announces Debenture Restructuring and Strategic Investor.
Monday October 19, 2010
Applied Visual Sciences announced today that, on October 15, 2010, it entered into an agreement with the holders of the company's outstanding Series A 10% Senior Convertible Debentures due November 7, 2008, that extends the maturity date of the debentures, provides that the debentures will be non-interest bearing through the date of maturity, and for certain other amendments to the terms of the debentures and related agreements.

Guardian Technologies Int'l Commends National Electrical Manufacturers Association (NEMA) on Publication of Digital Imaging and Communications in Security Standard (DICOS)
September 21, 2010
Guardian Technologies International, Inc. (OTCBB: GDTI), the homeland security subsidiary of Applied Visual Sciences, Inc. (OTCBB: APVS), congratulates the U.S. Department of Homeland Security and NEMA on the completion and publication of the essential new security standard, DICOS. This standard will enhance security screening and threat assessment processes across multiple vendor platforms at all critical infrastructure locations (airports, buildings, mass transit, ports, rail, and nuclear power plants) and other venues where large numbers of people congregate.

Guardian Technologies International Restructures, Changes Name to Applied Visual Sciences; Ticker Symbol Changes to APVS.
July 20, 2010
Applied Visual Sciences announced today that, on October 15, 2010, it entered into an agreement with the holders of the company's outstanding Series A 10% Senior Convertible Debentures due November 7, 2008, that extends the maturity date of the debentures, provides that the debentures will be non-interest bearing through the date of maturity, and for certain other amendments to the terms of the debentures and related agreements.